This article reviews clinical data informing the effective management of HER2-positive metastatic breast cancer, including the optimal sequence of HER2-targeted agents.
Danijela Jelovac, MD
Advertisement
Articles by Danijela Jelovac, MD
Advertisement
Latest Updated Articles
HER2-Directed Therapy for Metastatic Breast CancerMarch 15th 2013
Advertisement
Advertisement
Trending on CancerNetwork
1
Frontline Sunvozertinib Improves PFS vs Chemotherapy in EGFR+ NSCLC
2
The Evolution of Artificial Intelligence in Oncology: Impact on Trials, Workflows, and Outcomes
3
FDA Clears Investigator-Initiated IND for SRN-101 in Recurrent High-Grade Glioma
4
Navigating New Horizons in Neuroendocrine Prostate Cancer
5